Haemonetics Corp. (HAE)
122.94
+0.23
(+0.19%)
USD |
NYSE |
Nov 13, 16:00
122.90
-0.04
(-0.03%)
Pre-Market: 19:59
Haemonetics EPS Diluted (Quarterly) : 0.9966 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.9966 |
| June 30, 2026 | 0.7223 |
| March 31, 2026 | -0.4359 |
| December 31, 2025 | 0.9522 |
| September 30, 2025 | 0.8116 |
| June 30, 2025 | 0.7038 |
| March 31, 2025 | 1.172 |
| December 31, 2024 | 0.7404 |
| September 30, 2024 | 0.6602 |
| June 30, 2024 | 0.7442 |
| March 31, 2024 | 0.3962 |
| December 31, 2023 | 0.6073 |
| September 30, 2023 | 0.4846 |
| June 30, 2023 | 0.7994 |
| March 31, 2023 | 0.5736 |
| December 31, 2022 | 0.6432 |
| September 30, 2022 | 0.6439 |
| June 30, 2022 | 0.3846 |
| March 31, 2022 | 0.1897 |
| December 31, 2021 | 0.4525 |
| September 30, 2021 | 0.2887 |
| June 30, 2021 | -0.0874 |
| March 31, 2021 | -0.2171 |
| December 31, 2020 | 0.6207 |
| September 30, 2020 | 0.9414 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.2054 |
| March 31, 2020 | 0.3437 |
| December 31, 2019 | 0.5789 |
| September 30, 2019 | 0.7202 |
| June 30, 2019 | -0.1662 |
| March 31, 2019 | 0.399 |
| December 31, 2018 | 0.346 |
| September 30, 2018 | 0.3524 |
| June 30, 2018 | -0.0541 |
| March 31, 2018 | 0.22 |
| December 31, 2017 | -0.12 |
| September 30, 2017 | 0.38 |
| June 30, 2017 | 0.38 |
| March 31, 2017 | -0.98 |
| December 31, 2016 | 0.30 |
| September 30, 2016 | 0.38 |
| June 30, 2016 | -0.20 |
| March 31, 2016 | -0.17 |
| December 31, 2015 | -1.17 |
| September 30, 2015 | 0.25 |
| June 30, 2015 | -0.01 |
| March 31, 2015 | -0.06 |
| December 31, 2014 | 0.31 |
| September 30, 2014 | 0.14 |
| June 30, 2014 | -0.07 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Globus Medical, Inc. | 1.038 |
| Abbott Laboratories | 0.5294 |
| ICU Medical, Inc. | 1.068 |
| Merit Medical Systems, Inc. | 0.7008 |
| Teleflex, Inc. | 22.28 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 46.30M |
| Revenue (Quarterly) | 357.76M |
| Total Expenses (Quarterly) | 311.45M |
| Enterprise Value | 6.460B |
| Gross Profit Margin (Quarterly) | 58.78% |
| Profit Margin (Quarterly) | 12.94% |
| Earnings Yield | 1.82% |
| Operating Earnings Yield | 4.49% |
| Normalized Earnings Yield | 2.766 |